RhumbLine Advisers’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-604
Closed -$3.94K 4262
2026
Q1
$3.94K Hold
604
﹤0.01% 3896
2025
Q4
$3.45K Hold
604
﹤0.01% 3944
2025
Q3
$4.12K Hold
604
﹤0.01% 3928
2025
Q2
$5.42K Sell
604
-9,550
-94% -$56.6K ﹤0.01% 3920
2025
Q1
$54.6K Sell
10,154
-42
-0.4% -$285 ﹤0.01% 3550
2024
Q4
$76K Buy
10,196
+89
+0.9% +$732 ﹤0.01% 3552
2024
Q3
$91.4K Sell
10,107
-1,704
-14% -$17.6K ﹤0.01% 3521
2024
Q2
$125K Buy
11,811
+11,165
+1,728% +$119K ﹤0.01% 3443
2024
Q1
$5.69K Hold
646
﹤0.01% 3966
2023
Q4
$4.41K Hold
646
﹤0.01% 4005
2023
Q3
$6.3K Hold
646
﹤0.01% 3939
2023
Q2
$3.13K Buy
+646
New +$2.81K ﹤0.01% 4159
2021
Q2
Sell
-11,129
Closed -$92K 3105
2021
Q1
$92K Hold
11,129
﹤0.01% 2944
2020
Q4
$72K Buy
+11,129
New +$70.2K ﹤0.01% 2997
2020
Q3
Sell
-11,449
Closed -$80K 3043
2020
Q2
$80K Buy
+11,449
New +$83.7K ﹤0.01% 2992

Other funds holding ULBI

RhumbLine Advisers's ULBI Position: Q2 2026 in Review

RhumbLine Advisers sold out of Ultralife (ULBI) in Q2 2026, closing a stake of 604 shares — an estimated $3.94K sold.

RhumbLine Advisers first reported a position in ULBI in Q2 2020 and held it in 15 quarters. The position peaked at $125K in Q2 2024. 52 funds tracked by Wall St. Rank hold ULBI as of Q2 2026.

  • RhumbLine Advisers reported no remaining Ultralife position as of Q2 2026 after selling out during the quarter.
  • RhumbLine Advisers sold 604 Ultralife shares in Q2 2026, an estimated $3.94K.
  • RhumbLine Advisers first reported a position in Ultralife in Q2 2020 and held it in 15 quarters.
  • RhumbLine Advisers's Ultralife position peaked at $125K in Q2 2024.
  • 52 funds tracked by Wall St. Rank held Ultralife as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.